大动脉缩的二维模型中的生长:基于CFD信息的代理模型
Nasonkwe Hampwaye1, Jie Wang2, Alistair Revell2
1Centre for Research in Computational and Applied Mechanics, University of Cape Town, South Africa; Mechanical Engineering Department, University of Cape Town, South Africa.
Journal of biomechanics
|February 13, 2025
概括
一种基于代理的模型 (ABM) 预测了儿童的大动脉缩 (CoA) 的恶化. 该模型使用计算流体动力学 (CFD) 和比较医学来预测大动脉生长并识别风险.
科学领域:
- 生物医学工程 生物医学工程
- 计算生物学 计算生物学
- 心血管研究研究心血管研究
背景情况:
- 大动脉缩 (CoA) 由于差异生长,可以从无症状发展为严重.
- 个性化治疗需要对CoA患者的大动脉生长的预测模型.
研究的目的:
- 开发和验证一种基于代理的模型 (ABM),用于预测大动脉增长在大动脉缩 (CoA) 患者.
- 评估模型在不同物种和特定患者病例中的准确性.
主要方法:
- 一种多尺度的方法,结合了基于代理的建模 (ABM) 和计算流体动力学 (CFD) 的洞察力.
- 使用来自老鼠,猪和健康人类幼儿的数据开发特定物种的ABM.
- 经过验证的ABM的调整,以适应患者特异性的大动脉缩病例.
主要成果:
- 在动物模型和健康的幼儿中,对光半径 (79%-95%) 和生长率 (64%-90%) 的高预测精度.
- 患者特定的ABM预测到3岁时CoA恶化,高血压和血管损伤风险增加.
- 该模型确定了持久性CoA和分异性大动脉生长作为疾病进展的关键指标.
结论:
- 开发的ABM显示出预测大动脉生长和CoA进展的巨大潜力.
- 研究结果表明,需要将血管改造纳入ABM,以提高预测能力.
- 该模型可以帮助规划儿童COA患者的干预措施.
更多相关视频
相关概念视频
Development of Blood Vessels
2.1K
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
2.1K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
511
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
511


